Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson's Disease. [PDF]
Curr Neuropharmacol, 2023 Jing XZ +3 more
europepmc +1 more source
Behavioral studies of the effects of dopamine and 5-HT1A agonists in cynomolgus monkeys
, 1989 Eiji Mizuta +2 more
openalex +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Parkinson's disease (PD) is a neurodegenerative disorder associated with motor and nonmotor symptoms. Objectives This study assesses levodopa dose management, the therapeutic goals of clinicians, the factors that influence clinicians' choice of therapy, and the role of nonmotor symptoms using real‐world evidence from Germany, Italy,
Fabrizio Stocchi +2 more
wiley +1 more source
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms. [PDF]
Front Endocrinol (Lausanne), 2021 Pivonello C +6 more
europepmc +1 more source
Movement Disorders Clinical Practice, EarlyView.ABSTRACT Background Levodopa‐carbidopa intestinal gel infusion (LCIG) is an effective therapy for advanced Parkinson's disease (PD). Opicapone (OPC) is an enzyme inhibitor that enhances the bioavailability of levodopa in the brain. Objectives This study evaluates the effect of Opicapone addition in PD‐LCIG patients, assessing its impact on motor ...
Fabiana Colucci +9 more
wiley +1 more source
Dopamine agonists for preventing ovarian hyperstimulation syndrome. [PDF]
Cochrane Database Syst Rev, 2021 Tang H +4 more
europepmc +1 more source
Toward Understanding the Biology of a Complex Phenotype: Rat Strain and Substrain Differences in the Sensorimotor Gating-Disruptive Effects of Dopamine Agonists [PDF]
, 2000 Neal R. Swerdlow +7 more
openalex +1 more source
Longitudinal Study of Treatment Variability for Parkinson's Disease across Specialized Centers
Movement Disorders Clinical Practice, EarlyView.Abstract Background Real‐world evidence on treatment practices in Parkinson's disease (PD) has been limited due to the difficulty in collecting comprehensive and generalizable clinical data. Objectives We sought to identify treatment patterns and test how treatment changed in response to (1) falling, (2) worsening disease, and (3) worsening quality of ...
Nabila Dahodwala +11 more
wiley +1 more source
Dopamine Agonists in the Management of Non-Functioning Pituitary Adenomas. [PDF]
Acta Endocrinol (Buchar), 2021 Capatina C, Poiana C.
europepmc +1 more source
Effects of intravenous injection of dopamine D2 receptor agonists on striatal neurons of rats.
, 1993 Hiroaki Matsubayashi +2 more
openalex +1 more source